Photo credit: iStockphoto.
Photo credit: iStockphoto.

2 September 2013

Telesso Technologies Limited (ASX: TEO) today launched a $6.5 million capital raising in connection with its acquisition of IMB spin-out company Mimetica and its relisting on the Australian Securities Exchange (ASX). 

The funds will be used to support the Phase 2 clinical trial of Mimetica's potential breakthrough topical acne treatment MTC896.

Read more on the ASX website.

On this site

Go to top